To secure long term capital growth.
Name | % Net Assets |
---|---|
GlaxoSmithKline PLC | 7.9% |
Vodafone Group PLC | 6.6% |
Astrazeneca | 5.7% |
British American Tobacco PLC | 4.6% |
Unilever PLC | 4.3% |
Cable & Wireless PLC | 4.1% |
Cadbury PLC | 3.5% |
Morrison (WM) Supermarkets PLC | 3.2% |
Synergy Health PLC | 3.2% |
Compass Group PLC | 3.1% |
Key | % Net Assets |
---|---|
GlaxoSmithKline PLC | 7.9% |
Vodafone Group PLC | 6.6% |
Astrazeneca | 5.7% |
British American Tobacco PLC | 4.6% |
Other | 75.2% |
Date | 30-Mar-2012 |
---|---|
NAV | 302.59p |
Currency | GBP |
Change | -2.37p |
% | -0.78% |
YTD change | 302.59p |
YTD % | n/a |
Fund Inception | 01/12/1992 |
---|---|
Fund Manager | Richard Wilmot |
TER | 1.63 (30-Dec-2011) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £250 |
Savings | £50 |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.19 |
You are here: research